Welcome to My DNP Project Portfolio

(1) Adusumalli, S., Kanter, G. P., Small, D. S., Asch, D. A., Volpp, K. G., Park, S., Gitelman, Y., Do, D., Leri, D., Rhodes, C., VanZandbergen, C., Howell, J. T., Epps, M., Cavella, A. M., Wenger, M., Harrington, T. O., Clark, K., Westover, J. E., Snider, C. K., & Patel, M. S. (2022). Effect of Nudges to clinicians, patients, or both to increase statin prescribing: A cluster randomized clinical trial. JAMA Cardiology, 8(1), 23-30. https://doi.org/10.1001/jamacardio.2022.4373

(2) American Diabetes Association Professional Practice Committee (2024). Cardiovascular disease and risk management: Standards of care in diabetes – 2024. Diabetes Care 47(Supplement 1), s179-s218. https://doi.org/10.2337/dc24-S010

(3) Anderson, S. L., Marrs, J. C., Chachas, C. R., Cichon, B. S., Cizmic, A. D., Calderon, B. B., & Vlasimsky, T. B. (2020). Evaluation of a pharmacist-led intervention to improve statin use in persons with diabetes. Journal of Managed Care & Specialty Pharmacy, 26(7), 910-917. https://doi.org/10.18553/jmcp.2020.26.7.910

(4) Barankay, I., Reese, P. P., Putt, M. E., Russel, L. B., Loewenstein, G., Pagnotti, D., Yan, J., Zhu, J., McGilloway, R., Brennan, T., Finnerty, D., Hoffer, K., Chadha, S., & Volpp, K. G. (2020). Effect of patient financial incentives on statin adherence and lipid control: A randomized clinical trial. JAMA Network Open, 3(10). https://doi.org/10.1001/jamanetworkopen.2020.19429

(5) Butalia, S., Lee-Krueger, R. C. W., McBrien, K. A., Leung, A. A. C., Anderson, T. J., Quan, H., Naugler, C., Chen, G., & Campbell, D. J. T. (2020). Barriers and facilitators to using statins: A qualitative study with patients and family physicians. Canadian Cardiovascular Society, 2(6), 530–538. https://doi.org/10.1016/j.cjco.2020.07.002

(6) Butts, J. B. & Rich, K. L. (2018). Philosophies and theories for advanced nursing practice (3rd ed.). Jones & Bartlett Learning.

(7) CMS (n.d.a). Accountable care organizations (ACOs): General information. Centers for Medicare & Medicaid Services. Retrieved February 6, 2025, from https://www.cms.gov/priorities/innovation/innovation-models/aco

(8) CMS (n.d.b). Shared savings program: About the program. Centers for Medicare & Medicaid Services. Retrieved February 6, 2025, from https://www.cms.gov/medicare/payment/fee-for-service-providers/shared-savings-program-ssp-acos/about

(9) CMS (2025). 2025 Medicare advantage part D star ratings. Centers for Medicare & Medicaid Services. Retrieved February 6, 2025, from https://www.cms.gov/newsroom/fact-sheets/2025-medicare-advantage-and-part-d-star-ratings

(10) Halpert, K. D., Ward, K., & Sloane, P. D. (2022). Improving advance care planning documentation using reminders to patients and physicians: A longitudinal study in primary care. American Journal of Hospice & Palliative Medicine, 39(1), 62–67. https://doi.org/10.1177/10499091211004890

(11) Kim, S. W., Chen, J., Wegener, K. J., Resch, N. D., Neff, K. M., & Nawarskas, A. D. (2021). Improvement of statin utilization in veterans with diabetes through pharmacy interventions. American Diabetes Association, 39(2). https://doi.org/10.2337/figshare.13403342

(12) Kong, E., Beshears, J., Laibson, D., Madrian, B., Volpp, K., Loewenstein, G., Kolstad, J., & Choi, J. J. (2020). Do physician incentives increase patient medication adherence? Health Services Research, 55, 503-511. https://doi.org/10.1111/1475-6773.13322

(13) Labos, C. (2024). Cholesterol denialism is pseudoscience. Medscape. https://www.medscape.com/viewarticle/cholesterol-denialism-pseudoscience-2024a100083z?form=fpf

(14) Lim, S. C., Mustapha, F. I., Aagaard-Hansen, J., Calopietro, M., Aris, T., & Bjerre-Christensen, U. (2020). Impact of continuing medical education for primary healthcare providers in Malaysia on diabetes knowledge, attitudes, skills, and clinical practices. Medical Education Online, 25(1). https://doi.org/10.1080/10872981.2019.1710330

(15) Liberale, L., Carbone, F., Montecucco, F., & Sahebkar, A. (2020). Statins reduce vascular inflammation in atherogenesis: A review of underlying molecular mechanism. International Journal of Biochemistry and Cell Biology, 122. https://doi.org/10.1016/j.biocel.2020.105735

(16) Martin, C., Phillips, R., & Johnson, C. (2020). Improving provider awareness to statin prescribing guidelines: A quality improvement project. Journal of Vascular Nursing, 38(1), 25–28. https://doi.org/10.1016/j.jvn.2019.11.001

(17) Singh, K. B., Nnadozie, M. C., Adbal, M., Shrestha, N., Abe, R., A., M., Masroor, A., Khorochkov, A., Prieto, J., & Mohammed, L. (2021). Type 2 Diabetes and causes of sudden cardiac death: A systematic review. Cureus, 13(9). https://doi.org/10.7759/cureus.18145

(18) Stephens, A. B., Wynn, C. S., Hofstetter, A. M., Kolff, C., Pena, O., Kahn, E., Dasgupta, B., Natarajan, K., Vawdrey, D. K., Lane, M. M., Robbins-Milne, L., Ramakrishnan, R., Holleran, S., & Stockwell, M. S. (2021). Effect of electronic health record reminders for routine immunization and immunization needed for chronic medical conditions. Applied Clinical Informatics, 12(5), 1101–1109. https://doi.org/10.1055/s-0041-1739516

(19) Vonbank, A., Agewall, S., Kjeldsen, K. P., Lewis, B. S., Torp-Pedersen, C., Ceconi, C., Funk-Brentano, C., Kaski, J. C., Niessner, A., Tamargo, J., Walther, T., Wassmann, S., Rosano, G., Schmidt, H., Saely, C. H., & Drexel, H. (2017). Comprehensive efforts to increase adherence to statin therapy. European Heart Journal, 38, 2473-2477. https://doi.org/10.1093/eurheartj/ehw628

(20) Yu, J., Chen, W., Chen, M., Shia, B., & Wu, S. (2023). Effects of statin dose, class, and use intensity on all-cause mortality in patients with type 2 diabetes mellitus. Pharmaceuticals, 16(507). https://doi.org/10.3390/ph16040507